Activation of multiple cancer pathways and tumor maintenance function of the 3q amplified oncogene FNDC3B

References

• Stratton MR. Exploring the genomes of cancer cells: progress and promise. Science 2011; 331:1553 - 8; http://dx.doi.org/10.1126/science.1204040; PMID: 21436442
   PubMed Web of Science ®Google Scholar
• Lander ES. Initial impact of the sequencing of the human genome. Nature 2011; 470:187 - 97; http://dx.doi.org/10.1038/nature09792; PMID: 21307931
   PubMed Web of Science ®Google Scholar
• Sawey ET, Chanrion M, Cai C, Wu G, Zhang J, Zender L, et al. Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. Cancer Cell 2011; 19:347 - 58; http://dx.doi.org/10.1016/j.ccr.2011.01.040; PMID: 21397858
   PubMed Web of Science ®Google Scholar
• Zender L, Xue W, Zuber J, Semighini CP, Krasnitz A, Ma B, et al. An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell 2008; 135:852 - 64; http://dx.doi.org/10.1016/j.cell.2008.09.061; PMID: 19012953
   PubMed Web of Science ®Google Scholar
• Scott KL, Nogueira C, Heffernan TP, van Doorn R, Dhakal S, Hanna JA, et al. Proinvasion metastasis drivers in early-stage melanoma are oncogenes. Cancer Cell 2011; 20:92 - 103; http://dx.doi.org/10.1016/j.ccr.2011.05.025; PMID: 21741599
   PubMed Web of Science ®Google Scholar
• Tominaga K, Kondo C, Johmura Y, Nishizuka M, Imagawa M. The novel gene fad104, containing a fibronectin type III domain, has a significant role in adipogenesis. FEBS Lett 2004; 577:49 - 54; http://dx.doi.org/10.1016/j.febslet.2004.09.062; PMID: 15527760
   PubMed Web of Science ®Google Scholar
• Nishizuka M, Kishimoto K, Kato A, Ikawa M, Okabe M, Sato R, et al. Disruption of the novel gene fad104 causes rapid postnatal death and attenuation of cell proliferation, adhesion, spreading and migration. Exp Cell Res 2009; 315:809 - 19; http://dx.doi.org/10.1016/j.yexcr.2008.12.013; PMID: 19138685
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646 - 74; http://dx.doi.org/10.1016/j.cell.2011.02.013; PMID: 21376230
   PubMed Web of Science ®Google Scholar
• Kendall J, Liu Q, Bakleh A, Krasnitz A, Nguyen KC, Lakshmi B, et al. Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc Natl Acad Sci U S A 2007; 104:16663 - 8; http://dx.doi.org/10.1073/pnas.0708286104; PMID: 17925434
   PubMed Web of Science ®Google Scholar
• Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, et al. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 1999; 21:99 - 102; http://dx.doi.org/10.1038/5042; PMID: 9916799
   PubMed Web of Science ®Google Scholar
• Nanjundan M, Cheng KW, Zhang F, Lahad J, Kuo WL, Schmandt R, et al. Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesis. Mol Oncol 2008; 2:164 - 81; http://dx.doi.org/10.1016/j.molonc.2008.05.001; PMID: 19383336
   PubMed Web of Science ®Google Scholar
• Linxweiler M, Linxweiler J, Barth M, Benedix J, Jung V, Kim YJ, et al. Sec62 bridges the gap from 3q amplification to molecular cell biology in non-small cell lung cancer. Am J Pathol 2012; 180:473 - 83; http://dx.doi.org/10.1016/j.ajpath.2011.10.039; PMID: 22197383
   PubMed Web of Science ®Google Scholar
• Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 2009; 41:1238 - 42; http://dx.doi.org/10.1038/ng.465; PMID: 19801978
   PubMed Web of Science ®Google Scholar
• Pollack JR, Sørlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci U S A 2002; 99:12963 - 8; http://dx.doi.org/10.1073/pnas.162471999; PMID: 12297621
   PubMed Web of Science ®Google Scholar
• Kim RH, Wang D, Tsang M, Martin J, Huff C, de Caestecker MP, et al. A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction. Genes Dev 2000; 14:1605 - 16; PMID: 10887155
   PubMed Web of Science ®Google Scholar
• Kolligs FT, Kolligs B, Hajra KM, Hu G, Tani M, Cho KR, et al. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. Genes Dev 2000; 14:1319 - 31; PMID: 10837025
   PubMed Web of Science ®Google Scholar
• Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119:1420 - 8; http://dx.doi.org/10.1172/JCI39104; PMID: 19487818
   PubMed Web of Science ®Google Scholar
• Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, Downward J, et al. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 2002; 156:299 - 313; http://dx.doi.org/10.1083/jcb.200109037; PMID: 11790801
   PubMed Web of Science ®Google Scholar
• Tobin NP, Sims AH, Lundgren KL, Lehn S, Landberg G. Cyclin D1, Id1 and EMT in breast cancer. BMC Cancer 2011; 11:417; http://dx.doi.org/10.1186/1471-2407-11-417; PMID: 21955753
   PubMed Web of Science ®Google Scholar
• Wattenberg B, Lithgow T. Targeting of C-terminal (tail)-anchored proteins: understanding how cytoplasmic activities are anchored to intracellular membranes. Traffic 2001; 2:66 - 71; http://dx.doi.org/10.1034/j.1600-0854.2001.20108.x; PMID: 11208169
   PubMed Web of Science ®Google Scholar
• Gao YS, Alvarez C, Nelson DS, Sztul E. Molecular cloning, characterization, and dynamics of rat formiminotransferase cyclodeaminase, a Golgi-associated 58-kDa protein. J Biol Chem 1998; 273:33825 - 34; http://dx.doi.org/10.1074/jbc.273.50.33825; PMID: 9837973
   PubMed Web of Science ®Google Scholar
• Chen YG. Endocytic regulation of TGF-beta signaling. Cell Res 2009; 19:58 - 70; http://dx.doi.org/10.1038/cr.2008.315; PMID: 19050695
   PubMed Web of Science ®Google Scholar
• Mendelsohn R, Cheung P, Berger L, Partridge E, Lau K, Datti A, et al. Complex N-glycan and metabolic control in tumor cells. Cancer Res 2007; 67:9771 - 80; http://dx.doi.org/10.1158/0008-5472.CAN-06-4580; PMID: 17942907
   PubMed Web of Science ®Google Scholar
• Sotillo R, Hernando E, Díaz-Rodríguez E, Teruya-Feldstein J, Cordón-Cardo C, Lowe SW, et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 2007; 11:9 - 23; http://dx.doi.org/10.1016/j.ccr.2006.10.019; PMID: 17189715
   PubMed Web of Science ®Google Scholar
• Huesken D, Lange J, Mickanin C, Weiler J, Asselbergs F, Warner J, et al. Design of a genome-wide siRNA library using an artificial neural network. Nat Biotechnol 2005; 23:995 - 1001; http://dx.doi.org/10.1038/nbt1118; PMID: 16025102
   PubMed Web of Science ®Google Scholar
• Barrett JC, Crawford BD, Mixter LO, Schechtman LM, Ts’o PO, Pollack R. Correlation of in vitro growth properties and tumorigenicity of Syrian hamster cell lines. Cancer Res 1979; 39:1504 - 10; PMID: 427793
   PubMed Web of Science ®Google Scholar
• Yang X, Boehm JS, Yang X, Salehi-Ashtiani K, Hao T, Shen Y, et al. A public genome-scale lentiviral expression library of human ORFs. Nat Methods 2011; 8:659 - 61; http://dx.doi.org/10.1038/nmeth.1638; PMID: 21706014
   PubMed Web of Science ®Google Scholar
• Kumar A, Agarwal S, Heyman JA, Matson S, Heidtman M, Piccirillo S, et al. Subcellular localization of the yeast proteome. Genes Dev 2002; 16:707 - 19; http://dx.doi.org/10.1101/gad.970902; PMID: 11914276
   PubMed Web of Science ®Google Scholar
• Pelech S. Tracking cell signaling protein expression and phosphorylation by innovative proteomic solutions. Curr Pharm Biotechnol 2004; 5:69 - 77; http://dx.doi.org/10.2174/1389201043489666; PMID: 14965210
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004; 10:789 - 99; http://dx.doi.org/10.1038/nm1087; PMID: 15286780
   PubMed Web of Science ®Google Scholar
• Manning AL, Dyson NJ. pRB, a tumor suppressor with a stabilizing presence. Trends Cell Biol 2011; 21:433 - 41; http://dx.doi.org/10.1016/j.tcb.2011.05.003; PMID: 21664133
   PubMed Web of Science ®Google Scholar
• Shi Y, Massagué J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113:685 - 700; http://dx.doi.org/10.1016/S0092-8674(03)00432-X; PMID: 12809600
   PubMed Web of Science ®Google Scholar
• O’Connor PM, Jackman J, Bae I, Myers TG, Fan S, Mutoh M, et al. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res 1997; 57:4285 - 300; PMID: 9331090
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005; 102:15545 - 50; http://dx.doi.org/10.1073/pnas.0506580102; PMID: 16199517
   PubMed Web of Science ®Google Scholar
• Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006; 439:353 - 7; http://dx.doi.org/10.1038/nature04296; PMID: 16273092
   PubMed Web of Science ®Google Scholar
• Györffy B, Schäfer R. Biomarkers downstream of RAS: a search for robust transcriptional targets. Curr Cancer Drug Targets 2010; 10:858 - 68; http://dx.doi.org/10.2174/156800910793357916; PMID: 20718707
   PubMed Web of Science ®Google Scholar
• Turner N, Lambros MB, Horlings HM, Pearson A, Sharpe R, Natrajan R, et al. Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets. Oncogene 2010; 29:2013 - 23; http://dx.doi.org/10.1038/onc.2009.489; PMID: 20101236
   PubMed Web of Science ®Google Scholar
• Kao J, Pollack JR. RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes. Genes Chromosomes Cancer 2006; 45:761 - 9; http://dx.doi.org/10.1002/gcc.20339; PMID: 16708353
   PubMed Web of Science ®Google Scholar
• Lutterbach B, Zeng Q, Davis LJ, Hatch H, Hang G, Kohl NE, et al. Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival. Cancer Res 2007; 67:2081 - 8; http://dx.doi.org/10.1158/0008-5472.CAN-06-3495; PMID: 17332337
   PubMed Web of Science ®Google Scholar
• Turner N, Pearson A, Sharpe R, Lambros M, Geyer F, Lopez-Garcia MA, et al. FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer. Cancer Res 2010; 70:2085 - 94; http://dx.doi.org/10.1158/0008-5472.CAN-09-3746; PMID: 20179196
   PubMed Web of Science ®Google Scholar
• Guan Y, Kuo WL, Stilwell JL, Takano H, Lapuk AV, Fridlyand J, et al. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res 2007; 13:5745 - 55; http://dx.doi.org/10.1158/1078-0432.CCR-06-2882; PMID: 17908964
   PubMed Web of Science ®Google Scholar